Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 323

The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.

To kill a tumor cell: the potential of proapoptotic receptor agonists

Open access
Ashkenazi, Avi, Herbst, Roy S.·2008·Journal of Clinical Investigation

Abstract

Disturbances in mechanisms that direct abnormal cells to undergo apoptosis frequently and critically contribute to tumorigenesis, yielding a logical target for potential therapeutic intervention.There is currently heightened interest in the extrinsic apoptosis pathway, with several proapoptotic receptor agonists (PARAs) in development.The PARAs include the ligand recombinant human Apo2L/TRAIL and agonistic mAbs.Mechanistic and preclinical data with Apo2L/TRAIL indicate exciting opportunities for synergy with conventional therapies and for combining PARAs with other molecularly targeted agents.Novel molecular biomarkers may help identify those patients most likely to benefit from PARA therapy.Nonstandard abbreviations used: Apaf-1, apoptotic protease-activating factor 1; Apo2L/TRAIL, Apo2 ligand/TNF-related apoptosis-inducing ligand; BH3, Bcl-2 homology 3; CRC, colorectal cancer; DISC, death-inducing signaling complex; DLT, dose-limiting toxicity; IAP, inhibitor of apoptosis; MTD, maximum tolerated dose; NHL, non-Hodgkin lymphoma; NSCLC, non-small cell lung cancer; PARA, proapoptotic receptor agonist; PR, partial response; rhApo2L/TRAIL, recombinant human Apo2L/TRAIL; SAE, serious adverse event; SD, stable disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci34359

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 127 references

Cited by

See all 323

Metadata

Authors
Ashkenazi, A., & Herbst, R. S.
Venue
Journal of Clinical Investigation
Published
2008-06-02
Volume
118
Issue
6
Pages
1979-1990
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1964304371
Cited by
323
References
127
FWCI
17.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: To kill a tumor cell: the potential of proapoptotic receptor agonists. https://app.cochat.ai/papers/10.1172/jci34359
The paper
Ashkenazi, A., & Herbst, R. S. (2008). To kill a tumor cell: the potential of proapoptotic receptor agonists. Journal of Clinical Investigation. https://doi.org/10.1172/jci34359

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.